29 nuovi farmaci in commercio

0
231

ATOZET 30 cpr riv 10 mg + 40 mg ezetimibe/atorvastatina calcio triidrato
MSD ITALIA AIC:043543141 86,04€ C/RR in commercio dal:22/01/2018

GLIATILIN 10 cps 600 mg colina alfoscerato
ITALFARMACO AIC:025937032 19,50€ C/RR in commercio dal:05/02/2018

KEXROLT 30 cpr riv 10 mg + 40 mg ezetimibe/atorvastatina calcio triidrato
MSD ITALIA AIC:043247093 86,04€ C/RR in commercio dal:22/01/2018

ORVATEZ 30 cpr riv 10 mg + 40 mg ezetimibe/atorvastatina calcio triidrato
MSD ITALIA AIC:043249085 86,04€ C/RR in commercio dal:22/01/2018

OXERVATE collirio 7 flaconcini 20 mcg/ml 1ml cenegermin
DOMPE’ AIC:045383015 3507,00€ H/RNRL in commercio dal:24/01/2018

SEVITREX 28 cpr riv 20 mg + 5 mg + 12,5 mg olmesartan medoxomil/amlodipina besilato/idroclorotiazide
DAIICHI SANKYO AIC:041661024 26,84€ C/RR in commercio dal:19/01/2018

UPTRAVI 60 cpr riv 200 mcg selexipag
ACTELION AIC:044887026 7220,00€ A/RRL in commercio dal:22/01/2018

UPTRAVI 140 cpr riv 200 mcg selexipag
ACTELION AIC:044887038 16846,56€ A/RRL in commercio dal:22/01/2018

UPTRAVI 60 cpr riv 400 mcg selexipag
ACTELION AIC:044887040 7220,00€ A/RRL in commercio dal:22/01/2018

UPTRAVI 60 cpr riv 600 mcg selexipag
ACTELION AIC:044887053 7220,00€ A/RRL in commercio dal:22/01/2018

UPTRAVI 60 cpr riv 800 mcg selexipag
ACTELION AIC:044887065 7220,00€ A/RRL in commercio dal:22/01/2018

UPTRAVI 60 cpr riv 1000 mcg selexipag
ACTELION AIC:044887077 7220,00€ A/RRL in commercio dal:22/01/2018

UPTRAVI 60 cpr riv 1200 mcg selexipag
ACTELION AIC:044887089 7220,00€ A/RRL in commercio dal:22/01/2018

UPTRAVI 60 cpr riv 1400 mcg selexipag
ACTELION AIC:044887091 7220,00€ A/RRL in commercio dal:22/01/2018

UPTRAVI 60 cpr riv 1600 mcg selexipag
ACTELION AIC:044887103 7220,00€ A/RRL in commercio dal:22/01/2018

ATOSIBAN AGUETTANT EV 6,75 mg/0,9 ml atosiban acetato
LABORATOIRE AGUETTANT S.A. AIC:043675014 26,53€ H/OSP in commercio dal:23/01/2018

ATOSIBAN AGUETTANT EV 37,5 mg/5 ml atosiban acetato
LABORATOIRE AGUETTANT S.A. AIC:043675026 82,77€ H/OSP in commercio dal:23/01/2018

DURLEVATEC 3 cerotti 35 mcg/h buprenorfina
SANDOZ AIC:044388015 17,60€ A/RNR in commercio dal:25/01/2018

DURLEVATEC 3 cerotti 52,5 mcg/h buprenorfina
SANDOZ AIC:044388080 26,08€ A/RNR in commercio dal:25/01/2018

DURLEVATEC 3 cerotti 70 mcg/h buprenorfina
SANDOZ AIC:044388155 32,45€ A/RNR in commercio dal:25/01/2018

FINASTERIDE BIORGA 28 cpr riv 1 mg finasteride
LABORATOIRES BAILLEUL S.A. AIC:045269026 33,00€ Cnn / RNR in commercio dal:01/03/2018

FINASTERIDE BIORGA 84 cpr riv 1 mg finasteride
LABORATOIRES BAILLEUL S.A. AIC:045269040 78,00€ Cnn / RNR in commercio dal:01/03/2018

FORTACIN spray cut 5 ml 150 + 50 mg/ml lidocaina/prilocaina
RECORDATI AIC:043149020 39,40€ C/RR in commercio dal:05/02/2018

IRBESARTAN IDROCLOROTIAZIDE TEVA 28 cpr 300 mg + 12,5 mg irbesartan/idroclorotiazide
TEVA ITALIA AIC:041851294 7,79€ A/RR in commercio dal:25/01/2018

LANSOPRAZOLO MYLAN 28 cps 15 mg lansoprazolo
MYLAN AIC:036757045 6,72€ A/RR in commercio dal:26/01/2018

METOTREXATO ACCORD flaconcino 10 ml 100 mg/ml metotrexato
ACCORD AIC:044177071 220,00€ Cnn / OSP in commercio dal:29/01/2018

METRONIDAZOLO SALF EV 30 flaconcini 100 ml metronidazolo
SALF AIC:041491034 127,50€ C/OSP in commercio dal:01/02/2018

RISEDRONATO GENETIC 4 cpr riv 35 mg sodio risedronato
GENETIC AIC:042731012 10,98€ A/RR in commercio dal:22/01/2018

VINORELBINA ACCORD flaconcino 5 ml 10 mg/ml vinorelbina bitartrato
ACCORD AIC:045113026 100,65€ H/OSP in commercio dal:05/02/2018